Iatrogenic ventricular septal defects following transcatheter aortic valve implantation

Jonathan P Urbanczyk; Timothy A Mixon; Subbareddy Konda; Angel E Caldera

doi:10.1080/08998280.2022.2119543

Iatrogenic ventricular septal defects following transcatheter aortic valve implantation

Proc (Bayl Univ Med Cent). 2022 Sep 15;36(1):106-108. doi: 10.1080/08998280.2022.2119543. eCollection 2023.

Authors

Jonathan P Urbanczyk¹, Timothy A Mixon¹, Subbareddy Konda², Angel E Caldera²

Affiliations

¹ Department of Cardiology, Baylor Scott and White Medical Center - Temple, Temple, Texas.
² Department of Cardiology, Baylor Scott and White Medical Center - Round Rock, Round Rock, Texas.

Abstract

Ventricular septal defect (VSD) rarely occurs following transcatheter aortic valve implantation (TAVI). We report two patients who developed VSD following TAVI. One case was a Gerbode defect treated by percutaneous closure, and the second was a restrictive perimembranous VSD managed conservatively.

Keywords: Transcatheter aortic valve implantation; ventricular septal defect.

Publication types

Case Reports